Showing results (131-140 of 156) with videos related to

Sort By:
Pageof 16
International Journal of Oral and Maxillofacial Surgery|November 4, 2008
Comparison of chemically and pharmaceutically modified titanium and zirconia implant surfaces in dentistry: a study in sheepJ D Langhoff, K Voelter, D Scharnweber, et al.
Haematologica|October 12, 2000
Cytotoxic hepatosplenic gammadelta T-cell lymphoma following acute myeloid leukemia bearing two distinct gamma chains of the T-cell receptor. Biologic and clinical featuresE Weidmann, T Hinz, S Klein, et al.
International Journal of Clinical Pharmacy|March 6, 2023
How to write a successful grant application: guidance provided by the European Society of Clinical PharmacyAnita E Weidmann, Cathal A Cadogan, Daniela Fialová, et al.
AIDS (London, England)|April 13, 1999
Virological response to protease inhibitor therapy in an HIV clinic cohortS Staszewski, V Miller, C Sabin, et al.
British Journal of Haematology|February 13, 2001
T-large granular lymphocyte leukaemia with natural killer cell-like cytotoxicity and expression of two different alpha- and beta-T-cell receptor chainsS Boehrer, T Hinz, D Schui, et al.
Nature|September 22, 1994
Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiologyB Conrad, E Weidmann, G Trucco, et al.
Equine Veterinary Journal|February 24, 2001
Comparison of radiography and scintigraphy in the diagnosis of dental disorders in the horseR Weller, L Livesey, J Maierl, et al.
International Journal of Clinical Pharmacy|February 9, 2024
Writing a manuscript for publication in a peer-reviewed scientific journal: Guidance from the European Society of Clinical PharmacyFrancesca Wirth, Cathal A Cadogan, Daniela Fialová, et al.
Cancer|July 15, 1993
Interferon-alpha and interleukin-2 in the treatment of metastatic melanoma. Comparison of two phase II trialsU Keilholz, C Scheibenbogen, W Tilgen, et al.
The Journal of Infectious Diseases|July 9, 1999
CD4 lymphocyte count as a predictor of the duration of highly active antiretroviral therapy-induced suppression of human immunodeficiency virus loadV Miller, S Staszewski, C Sabin, et al.
Pageof 16